Prostate cancer decisions — 2007

The Board has denied the veteran's claims for service connection for prostate cancer, kidney cancer, depression, hypertension, hearing loss, tinnitus, eye sight problems, and a heart disorder manifested by premature ventricular contractions due to Agent Orange exposure.

The medical evidence does not show any voiding dysfunction or urinary incontinence, so the veteran's service-connected residuals of prostate cancer cannot be rated higher than 10 percent.

The Board denied the veteran's claim for an increased evaluation for his service-connected recurrent lumbar strain and also denied his attempt to reopen his claim for prostate cancer, which he claimed was due to Agent Orange exposure.

The Board denied the veteran's claim for service connection for a genitourinary disorder, apart from prostate cancer and manifested by hematuria, urgency, and frequency.

The Board denied the veteran's claim for service connection for prostate cancer, finding no evidence of a disability during service or actual exposure to herbicides. The preponderance of the evidence is against the claim.

The veteran's claims for service connection for prostate cancer, post-traumatic stress disorder, and bronchial pneumonia were denied. The Board found no evidence of exposure to herbicide agents or combat duty that would support the presumption of service connection.

The veteran's claim for service connection for prostate cancer, claimed as due to exposure to radiation and/or asbestos, is being remanded for additional development.

The Board has determined that the veteran's prostate cancer was not incurred in or aggravated by active service and may not be presumed to have been incurred or aggravated therein.

The Board found that the veteran's death was not caused by his military service or his service-connected disabilities, and thus denied the claim for service connection for the cause of the veteran's death.

The Board has denied the veteran's claim for service connection for prostate cancer, finding that it is not related to his in-service exposure to ionizing radiation and is not otherwise a result of a disease or injury in service.

The veteran's claims for service connection for degenerative joint disease of the cervical spine, right ear hearing loss, and prostate cancer were denied as there is no competent evidence linking these conditions to his military service.

The Board has granted a 10 percent rating for the veteran's service-connected prostate cancer status post radiation, effective from the date of the July 2004 rating decision. The veteran is not shown to have erectile dysfunction due to disease or injury that was incurred in or aggravated by service.

The Board found that the reduction of the veteran's prostate cancer evaluation from 100 percent to 40 percent in December 2001 was improper due to inadequate VA examinations and lack of sustained improvement.

The Board has remanded the case for further development, including scheduling a Travel Board hearing.

The Board has denied the veteran's claim for service connection for prostate cancer, finding that there is no competent evidence linking his current condition to service. The issue of what evaluation is warranted for PTSD from August 7, 2003 remains pending.

The Board denied the veteran's service connection claims for prostate cancer, peripheral neuropathy, hair loss, sleep disorder, and depression, all claimed as due to herbicide exposure. The evidence did not show a causal relationship between these conditions and his military service.

The Board found that the cause of the veteran's death was not service-connected, and there is no legal basis for dependents' educational assistance benefits.

The veteran's death was not caused by a service-connected disability, and the statutory criteria for DIC benefits under 38 U.S.C.A. § 1318 were not met.

The veteran's prostate cancer was not present within one year of discharge and is not etiologically related to service. Service connection for prostate cancer is denied.

The veteran withdrew his appeal for the claims of increased ratings for peripheral neuropathy in the upper and lower bilateral extremities, as well as his claims for service connection for bladder and foot conditions secondary to service-connected prostate cancer.